Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
Hs 578T
TNBC
Basal B
Cetuximab
EGFR
ErbB
7864.042
uM
inf
inf
0.9446 0.9446 0.0000 -0.0078
-0.0792
1.4812
Hs 578T
TNBC
Basal B
Cetuximab
EGFR
ErbB
7863.018
uM
inf
inf
0.9678 0.9678 0.0000 0.0287
0.0694
2.0946
Hs 578T
TNBC
Basal B
Cetuximab
EGFR
ErbB
7862.042
uM
inf
inf
0.8300 0.8300 0.0000 0.0340
0.2783
1.2756
Hs 578T
TNBC
Basal B
Cetuximab
EGFR
ErbB
7861.018
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.8485
Hs 578T
TNBC
Basal B
CGC-11047
Polyamine analogue
7863.018
uM
93.13020
1000.00000
-0.7605 -0.9551 0.4500 0.3964
0.6501
2.0946
Hs 578T
TNBC
Basal B
CGC-11047
Polyamine analogue
9511.034
uM
13.69580
390.94370
-0.9614 -1.0000 0.3278 0.5398
0.7280
1.1177
Hs 578T
TNBC
Basal B
CGC-11047
Polyamine analogue
7861.018
uM
846.11220
1000.00000
-0.9642 -0.6530 5.0000 0.1076
0.8583
0.8485
Hs 578T
TNBC
Basal B
Chloroquine
12622.177
uM
5.16760
8.74240
-0.6678 -0.7210 1.6981 0.2810
0.9997
2.5433
Hs 578T
TNBC
Basal B
Cisplatin
DNA cross-linker
DNA cross-linker
7863.017
uM
inf
2.42270
0.1619 0.5028 4.9973 0.1923
0.6588
1.9568
Hs 578T
TNBC
Basal B
Cisplatin
DNA cross-linker
DNA cross-linker
7862.017
uM
7.34780
15.84620
-0.9530 -1.0000 1.4295 0.5016
0.9788
1.3198
Hs 578T
TNBC
Basal B
Cisplatin
DNA cross-linker
DNA cross-linker
7864.017
uM
8.55240
17.46430
-0.8895 -0.9609 1.5018 0.4529
0.9837
1.6561
Hs 578T
TNBC
Basal B
Cisplatin
DNA cross-linker
DNA cross-linker
7861.017
uM
6.17520
9.16460
-0.4540 -0.4589 1.6494 0.3832
0.9920
1.8068
Hs 578T
TNBC
Basal B
Cisplatin
DNA cross-linker
DNA cross-linker
9511.021
uM
16.3020
24.45550
-0.8220 -0.8295 2.4113 0.3461
0.9963
1.3466
Hs 578T
TNBC
Basal B
CPT-11
TOP1
TOP
7863.007
uM
inf
52.97460
0.7011 0.5937 3.0757 -0.0133
0.8737
1.4578
Hs 578T
TNBC
Basal B
CPT-11
TOP1
TOP
9511.034
uM
13.67290
28.5270
-0.6245 -1.0000 1.4938 0.2054
0.9797
1.1177
Hs 578T
TNBC
Basal B
Dactolisib
PI3K
PI3K
10694.146
uM
inf
0.59404
0.9321 0.9482 4.9147 0.0057
0.5761
2.2821
Hs 578T
TNBC
Basal B
Dichloroacetate
PDK
PDK
12622.176
uM
inf
inf
0.9947 0.9947 0.0000 -0.0101
-0.9347
2.5005
Hs 578T
TNBC
Basal B
Disulfiram
Proteasome
Proteasome
12622.174
uM
7.57420
16.26170
-0.8300 -1.0000 1.4378 0.2836
0.9641
2.4358
Hs 578T
TNBC
Basal B
Docetaxel
TUBB
TUBB
7864.002
uM
0.00202
0.00368
-0.4182 -0.4089 1.0008 0.8906
0.9829
1.5910
Hs 578T
TNBC
Basal B
Docetaxel
TUBB
TUBB
9511.002
uM
0.00153
0.00209
-0.4596 -0.4491 2.0361 0.9639
0.9856
1.1960
Hs 578T
TNBC
Basal B
Doxorubicin
TOP2
TOP
7863.007
uM
3.32340
4.93410
-0.5852 -0.6262 2.0549 0.3704
0.9741
1.4578
Hs 578T
TNBC
Basal B
Doxorubicin
TOP2
TOP
9511.034
uM
0.10151
0.39355
-0.9726 -0.8874 0.7531 0.7665
0.9843
1.1177
Hs 578T
TNBC
Basal B
Epirubicin
TOP2
TOP
7862.017
uM
0.34445
1.15410
-0.9973 -0.9467 0.8787 0.7815
0.9793
1.3198
Hs 578T
TNBC
Basal B
Epirubicin
TOP2
TOP
7863.017
uM
0.45185
1.31370
-0.9777 -0.8120 0.9039 0.6605
0.9795
1.9568
Hs 578T
TNBC
Basal B
Epirubicin
TOP2
TOP
7864.017
uM
0.36656
0.99035
-0.9870 -0.8360 0.9889 0.7176
0.9860
1.6561